Innovative HIV Medication Patch
October 2011
Stations, the following is
a news announcement. Suggested lead in 3, 2, 1…
(INTRO)
An innovative delivery method
for HIV medications has been developed using a transdermal
patch, the first of its kind to treat HIV. This research
is being presented at the 2011 American Association
of Pharmaceutical Scientists Annual Meeting and Exposition
in Washington, D.C. from October 23 to 27.
Researcher Anthony Ham, PhD,
from ImQuest Biosciences in Frederick, Maryland, describes
the single dose patch.
(HAM)
AS WE ENTER THE FOURTH DECADE
OF H-I-V/AIDS, THIS DELIVERY METHOD WILL HOPEFULLY REDUCE
THE NUMBER OF PILLS MOST H-I-V PATIENTS HAVE TO TAKE
DAILY. THIS IS IMPORTANT BECAUSE TAKING MEDICATIONS
REGULARLY REDUCES SYMPTOMS AND EXTENDS LIVES, AND THE
PATCH ALLOWS FOR EASIER COMPLIANCE. THE PATCH IS ALSO
POTENTIALLY LESS EXPENSIVE TO MANUFACTURE AND SHIP THAN
PILLS OR NEEDLES. WITH AN ESTIMATED FIFTEEN MILLION
PEOPLE LIVING WITH H-I-V IN DEVELOPING COUNTRIES AND
ONLY FIVE-POINT-THREE MILLION WITH ACCESS TO TREATMENT,
THIS IS A MORE AFFORDABLE AND ACCESSIBLE TREATMENT METHOD.
(CLOSE)
For more information, visit
www.aaps.org.
###
|
